On October 5th The Healthcare Distribution Alliance (HDA) announced that Robert Mauch, PharmD, PhD, EVP and Group President of AmerisourceBergen Corporation and Chad Gielen, President/CEO of Louisiana Wholesale Drug Co. Inc. will lead board of directors.
Robert Mauch who was HDA Vice Chairman for two years, expectedly take Board leadership from Greg Drew, RPh, President of Value Drug Company. Greg Drew in his turn, will stay a member of the HDA Executive Committee, which executes HDA’s strategic priorities on behalf of the organization’s Board of Directors.
“I want to welcome Bob and Chad into their new roles, while thanking Greg for his leadership, guidance and service to the pharmaceutical distribution industry during a pivotal time,” said HDA President and CEO Chester “Chip” Davis, Jr. “As we continue the work of communicating the value distributors provide to the overall healthcare ecosystem, I look forward to working in concert with our Executive Committee and Board of Directors to ensure HDA is effectively serving its membership, both today and in the future.”
The HDA history starts on March 15, 1876, during the first annual convention of 95 wholesale druggists (representing 16 cities, from Cleveland to St. Louis, and 11 states) at the Exchange Hall in Indianapolis.
The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and pharmacies, hospitals, long-term care facilities, clinics and others nationwide.
Today the alliance counts more than 130 manufacturers and more than 50 service provider/international members, respectively. These members serve more than 200,000 licensed healthcare providers, delivering over 15 million lifesaving products to these outlets every day.
Healthcare Distribution Alliance (HDA) Executive Committee
To date The Executive Committee consists of the “members of the Board of Directors representing each distributor member at the capped dues level, and an equal number plus one of the Board members representing distributor members not at the capped dues level, as selected by the Board. Among the members of the Executive Committee is a chairperson and a vice-chairperson,” – HDA said.
The president and CEO is an ex officio non-voting member of the Executive Committee. The Executive Committee’s authority includes approval of the annual Alliance budget and the execution of priorities, policies and positions of the organization as identified and developed by the Board of Directors.
“While this has been an unprecedented year, I continue to be amazed and humbled by the work, dedication and perseverance of our healthcare distribution industry to serve patients, protect the supply chain and efficiently deliver essential, lifesaving products every day — even in the most challenging of times,” said Bob Mauch. “I am proud to take on this new role with the understanding that partnership, collaboration and the ability of our industry to innovate will ultimately have the greatest impact on both patients and the healthcare ecosystem.”
“I am proud to continue to lend my voice and perspective during a critical time for HDA and the distribution industry, while helping to guide the continued growth of this association,” said Chad Gielen. He has served as a member of the Board of Directors for five years, with two of those years on the Executive Committee.
Be the first to comment on "Healthcare Distribution Alliance (HDA)"